Stockscreener 앱 받기
0.7522
4.54%
-0.0358
시간 외 거래:
.75
-0.0022
-0.29%
Oragenics Inc 주식(OGEN)의 최신 뉴스
Oragenics Files 2025 Annual Report, Highlights Progress in Concussion Treatment Development - citybuzz -
Oragenics Submits Annual Report Highlighting Fiscal Year 2025 Financials and Research Updates - geneonline.com
ORAGENICS FILES ANNUAL REPORT ON FORM 10-K - The Manila Times
Biotech Oragenics raises $16.5M, clears debt to fund concussion drug trial - Stock Titan
Oragenics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION - Sahm
Oragenics Initiates First Clinical Site for Phase IIa Trial of Intranasal Concussion Treatment - citybuzz -
Oragenics Inc Initiates Phase Iia Clinical Trial Site Activation - marketscreener.com
Oragenics (OGEN) Advances Phase IIa Clinical Trial of ONP-002 in Australia - GuruFocus
Oragenics begins testing nasal concussion treatment in Australia - Stock Titan
Oragenics Receives Australian HREC Approval to Begin Phase IIa Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury - Minichart
Oragenics Advances Concussion Drug Trial and Explores CNS Asset Acquisitions - TipRanks
Oragenics Explores CNS Asset Acquisitions to Expand Brain Health Pipeline - citybuzz -
Oragenics (OGEN) Eyes Expansion in Central Nervous System Sector - GuruFocus
ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION - The Manila Times
Oragenics (OGEN) Receives Approval for Phase IIa Concussion Drug Trial in Australia - GuruFocus
New nasal concussion drug candidate cleared for patient trial in Australia - Stock Titan
Oragenics Receives Ethics Approval for Phase IIa Concussion Trial in Australia - citybuzz -
Is Oragenics Inc forming bullish engulfing patterns2025 Key Highlights & Daily Momentum Trading Reports - baoquankhu1.vn
Inflation Data: Is Oragenics Inc a strong candidate for buy and holdJuly 2025 Sentiment & High Return Trade Guides - baoquankhu1.vn
OGEN SEC FilingsOragenics 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Technicals: What is the target price for Oragenics Inc stockPortfolio Performance Report & Momentum Based Trading Signals - baoquankhu1.vn
OGEN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Momentum Shift: Is Oragenics Inc vulnerable to short sellersJuly 2025 Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
How Oragenics Inc. stock trades pre earningsJuly 2025 Pullbacks & Risk Managed Investment Entry Signals - mfd.ru
OGEN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Can Oragenics Inc. sustain its profitabilityJuly 2025 Macro Moves & Consistent Return Investment Signals - mfd.ru
Is Oragenics Inc. vulnerable to short sellers2025 Key Lessons & Verified Chart Pattern Signals - mfd.ru
Oragenics previews targeted milestones for 2026 - Yahoo Finance
Oragenics (OGEN) Progresses ONP-002 for Potential $9 Billion Con - GuruFocus
Oragenics Targets Projected $9 Billion Market by Advancing - GlobeNewswire
Portfolio Shifts: What is the next catalyst for Oragenics IncJuly 2025 Closing Moves & Consistent Return Investment Signals - baoquankhu1.vn
Oragenics partners with Duck Flats Pharma to support FDA IND trial design - Yahoo Finance
Oragenics (OGEN) Partners with Duck Flats Pharma for U.S. IND Re - GuruFocus
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program - Sahm
Oragenics Advances Concussion Treatment Development with SCOPE Summit Participation Ahead of Australian Phase 2a Trial - citybuzz -
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care - GlobeNewswire
Investor Mood: Is Oragenics Inc stock technically oversold2025 Risk Factors & Growth Focused Stock Reports - baoquankhu1.vn
Market Trends: Is now the right time to enter LPLAWeekly Trade Summary & Reliable Breakout Forecasts - baoquankhu1.vn
Rate Hike: What is the next catalyst for Oragenics IncQuarterly Portfolio Summary & Verified Entry Point Detection - baoquankhu1.vn
Oragenics Extends At-the-Market Equity Sales Agreement - The Globe and Mail
Oragenics amends at-the-market sales agreement with Dawson James Securities By Investing.com - Investing.com Australia
Oragenics amends at-the-market sales agreement with Dawson James Securities - Investing.com
Oragenics Signs Amendment to At-the-Market Sales Agreement With Dawson James Securities - TradingView
Telling Fred sells Oragenics (OGEN) shares for $198 By Investing.com - Investing.com Nigeria
Telling Fred sells Oragenics (OGEN) shares for $198 - Investing.com
Why High Roller Technologies Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket - Benzinga
Sell Signal: What is the target price for Oragenics Inc stockJuly 2025 Short Interest & Fast Moving Trade Plans - baoquankhu1.vn
Aug Chart Watch: What is the next catalyst for Oragenics IncWeekly Earnings Recap & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Oragenics (NYSEAMERICAN:OGEN) Shares Up 1.9% – Should You Buy? - Defense World
Oragenics to Showcase Concussion Treatment Progress at Investor Summit - citybuzz -
Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico - marketscreener.com
OGENOragenics Latest Stock News & Market Updates - Stock Titan
Will Oragenics Inc. stock sustain bullish trend into 2025Portfolio Risk Report & Reliable Intraday Trade Plans - Улправда
Why Oragenics Inc. stock is favored by top institutionsMarket Trend Report & Fast Entry and Exit Trade Plans - Улправда
Can Oragenics Inc. stock deliver surprise earnings beatEarnings Growth Summary & Stepwise Entry and Exit Trade Signals - Улправда
Can Oragenics Inc. stock beat market expectations this quarter2025 Winners & Losers & Community Consensus Trade Alerts - Улправда
Investment Recap: Is Oragenics Inc stock attractive after correctionJuly 2025 News Drivers & Reliable Momentum Entry Alerts - Bộ Nội Vụ
1.20%
0.06%
자본화:
|
볼륨(24시간):